Yunshan Yang Selected Research

Melanoma (Melanoma, Malignant)

6/2012

Activated T cell exosomes promote tumor invasion via Fas signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunshan Yang Research Topics

Disease

14	Neoplasms (Cancer) 05/2022 - 05/2007
6	Stomach Neoplasms (Stomach Cancer) 04/2017 - 11/2008
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2015
2	Hyperthermia 01/2018 - 01/2015
2	Disease Progression 04/2017 - 11/2008
1	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2022
1	B-Cell Leukemia (Leukemia, B Cell) 05/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2022
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2016
1	Colorectal Neoplasms (Colorectal Cancer) 12/2014
1	Pain (Aches) 11/2012
1	Melanoma (Melanoma, Malignant) 06/2012
1	Ascites 01/2011
1	Ovarian Neoplasms (Ovarian Cancer) 11/2009
1	Retinoblastoma (Glioblastoma, Retinal) 11/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2007
2	Pharmaceutical PreparationsIBA 05/2022 - 01/2016
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021 - 11/2009
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2009
2	SuperantigensIBA 02/2020 - 05/2007
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	Sucrose (Saccharose)IBA 01/2011 - 06/2007
2	Cancer VaccinesIBA 06/2007 - 05/2007
2	Interleukin-2 (IL2)IBA 06/2007 - 05/2007
1	Chimeric Antigen ReceptorsIBA 05/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	CarcinogensIBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	SaltsIBA 10/2016
1	Dextran SulfateIBA 10/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	fascinIBA 01/2015
1	fibrin fragment D (D-dimer)IBA 12/2014
1	Bevacizumab (Avastin)FDA Link 12/2014
1	Capecitabine (Xeloda)FDA Link 07/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2014
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2011
1	Cyclin D1IBA 11/2009
1	Cyclin AIBA 11/2009
1	Cyclin EIBA 11/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2008
1	Docetaxel (Taxotere)FDA Link 11/2008
1	PlatinumIBA 11/2008
1	OvalbuminIBA 06/2007
1	AntigensIBA 06/2007
1	Staphylococcal enterotoxin AIBA 05/2007

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2019 - 11/2008
5	Therapeutics 01/2015 - 11/2008
2	Combination Drug Therapy (Combination Chemotherapy) 07/2014 - 11/2008
1	Hyperthermic Intraperitoneal Chemotherapy 08/2016
1	Precision Medicine 01/2016
1	Acetabuloplasty 11/2012
1	Cementoplasty 11/2012
1	Immunotherapy 05/2007